Cylerity

About Cylerity

Cylerity Accelerated Finance is a financial technology company focused on optimizing cash flow for healthcare providers by providing rapid advances on third-party payer accounts receivable. Their mission is to address financial stress in healthcare by accelerating reimbursements from insurance companies and Medicare, particularly for rural and critical access hospitals.

Products & Services

Cylerity Platform:A financial technology platform that values and collateralizes medical reimbursement claims in near real-time, offering advances of 70-90% of claims within 48 hours of submission. It provides lower-cost financing options for Medicare and commercial insurance claims, maximizes value with high advance amounts, minimizes costs with risk pricing based on payers' credit ratings, and ensures financing flexibility without blanket liens.

Specialties

Healthcare Accounts Receivable Financing Cash Flow Acceleration Proprietary Valuation Algorithms Medical Reimbursement Claims Collateralization

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 4000000 MR: - FA: 4 million FAN: 4000000	D: 2025-10-28 FD: 2025-10-28	6 investors

Seed Latest

2025-10-28

$4.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Eletrope

B

Buckminster Fuller

Recent News

Cylerity Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised